Photo Credit: VM
The Following is a summary of “Underutilized Treatments for Patients with refractory cancer: A QUALITIVE STUDY ASSESING the use of intrathecal Drug Delivery Devices in the united Kingdom compared to alternative treatments in cancer pain Management,” published in the januarary 2025 ISSUE OFF Pain by Buschman et al.
The Research Aimed to Clarified How Intrathecal Drug Delivery Systems (IDDS) Were Integrated into the Oncology Care Continuum and Emphasized the Need for Greater Awareness of Interventional Pain Management Options for Patients with Cancer in the United Kingdom.
Researchers Drived the Retrospective Study to Analyze the Knowledge, Perspectives, and Experiences of Healthcare Professionals Regarding the Use of Idds for Managing Chronic Refractory pain in pates with cancer.
They Caried Out Semi-Structured InterViews with 18 Healthcare Professionals from Specialties Such As Oncology, Neurosurgery, Pain Management, and Palliative Care. The Interviews Were Transcribed, and A 2-Phased Qualitative Inductive Coding Approach Was Employed to Analyze the Data.
The Results Showed 4 Key Themes: A Need for Increeded Education on Idds Among Healthcare Professionals, Concerns Regarding Infection Risks, Suitability for Patients with short life Life Expectancy, and Challenges of Idds Use. Technical and Administrative Issues, Such As Cost, Device Management, and the Need for Improved Guidelines, Were Also Identified. Patient-Care Care Was Underlined, HighLighting the Importance of Involving Patients in Decision-Making and Considering the Well-Being. The Research Also Identified Gaps in Managing Refractory Pain, Including the Need for More Including Guidelines, Increured Awareness, and Better Collaboration with Medical Technology Companies.
Investigators concluded that the idds improved pain control, emphasizing the importance of early intervention and comprehensive pain management to influence the course of oncological dissees.
Source: Frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1481245/abstract
